EXACT SCIENCES CORP (EXAS) Net Cash Flow (2010 - 2025)

Exact Sciences (EXAS) has reported Net Cash Flow for 16 consecutive years, with $166.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Net Cash Flow rose 963.95% year-over-year to $166.9 million in Q4 2025; TTM through Dec 2025 was $348.5 million, a 136554.51% increase from a year earlier, with the FY2025 full-year figure at $348.5 million, up 136554.51% from the prior year.
• Net Cash Flow was $166.9 million for Q4 2025 at Exact Sciences, up from $131.9 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $309.4 million in Q2 2025 and troughed at -$740.1 million in Q2 2021.
• A 5-year average of -$26.7 million and a median of $19.9 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow tumbled 25851.15% in 2021 and surged 963.95% in 2025, its largest moves.
• Over 5 years, Net Cash Flow stood at $41.7 million in 2021, then plunged by 90.45% to $4.0 million in 2022, then soared by 222.0% to $12.8 million in 2023, then grew by 22.4% to $15.7 million in 2024, then surged by 963.95% to $166.9 million in 2025.
• The last three Net Cash Flow figures came in at $166.9 million (Q4 2025), $131.9 million (Q3 2025), and $309.4 million (Q2 2025), per Business Quant data.